{"paper_id":"54484602-e2cf-49aa-b45b-be58fe061678","body_text":"Conference Materials \nThe risk of endometriosis-associated ovarian cancer       \nJohnny Younis1 \n1 The Azrieli Faculty of Medicine, Bar-Ilan University \nKeywords: endometriosis, ovarian cancer, infertility, nulliparity, hyperestrogenism \nhttps://doi.org/10.46989/001c.126484 \nJournal of IVF-Worldwide \nVol. 2, Issue 4.1, 2024 \n  \nURL: https://www.youtube.com/embed/ZCMu5C2Thso \nIn this in-depth and informative video, Prof. Johnny \nYounis, from Israel, takes the audience on a profound ex-\nploration of the intricate relationship between endometrio-\nsis and the potential development of ovarian cancer. The \ncore premise revolves around the understanding that while \nendometriosis itself doesn’t serve as a direct cause of can-\ncer, there’s a discernible increase in the risk of specific ovar-\nian cancers for individuals dealing with endometriosis. This \nnuanced insight is foundational to the entire discussion. \nClear cell and endometrioid ovarian carcinomas, as em-\nphasized by the speaker, are notably linked to endometrio-\nsis, establishing a strong association between the two. \nHowever, the linkage isn’t as clearly defined for other ovar-\nian malignancies, underlining the complexity of this med-\nical phenomenon. The lifetime risk of encountering en-\ndometriosis-associated ovarian cancer is estimated to hover \naround 2.1 percent, a statistically low figure compared to \nthe prevalence of various other forms of cancer. This statis-\ntical insight is crucial for contextualizing the risks associ-\nated with endometriosis in the realm of broader health con-\ncerns. \nOne pivotal aspect pertains to the challenge of distin-\nguishing between a benign endometrioma and endometrio-\nsis-associated ovarian cancer, a task of utmost importance \nfor informed medical decisions. The video meticulously de-\nlineates various risk factors that come into play during the \ndiagnostic process. Factors like advanced age, pelvic pain \nsymptoms, long-lasting endometriosis, nulliparity, infertil-\nity, hyperestrogenism, and an enlarged endometrioma play \nsignificant roles in this differentiation. Additionally, the \ndiscussion brings to light the significance of cutting-edge \ndiagnostic tools such as transvaginal ultrasound and MRI, \nilluminating how they can be invaluable in making accurate \ndistinctions. \nThe discourse doesn’t merely touch on the medical as-\npects; it delves deep into the controversial domain of treat-\nment, especially the surgical intervention route. While \nsurgery is advocated by some as a potential remedy, es-\npecially for addressing infertility linked to endometriosis, \nthere’s a counterargument challenging its robustness in en-\nhancing fertility. The potential adverse effects of surgery \non ovarian reserve, reproductive capacity, and the need for \nrepetitive operations are carefully weighed, thus ensuring a \nbalanced view of the treatment landscape. \nFurthermore, the speaker illuminates the importance of \na multidisciplinary approach, asserting that decisions \nshouldn’t be solely dictated by the potential risk of en-\ndometriosis-associated ovarian cancer. This critical insight \nemphasizes individualized and careful evaluation of each \ncase, taking into account a multitude of factors. \nThe video underscores the need for vigilant monitoring, \nparticularly for women showcasing symptoms of en-\ndometriosis and those with substantial endometriomas. It \nemphasizes that the risk, while existing, is still relatively \nlow compared to other health concerns. This balanced per-\nspective ensures a comprehensive understanding of the sit-\nuation without undue alarm. \nIn summation, the presentation thoroughly explores a \ncomplex medical topic, amalgamating scientific intricacies \nwith practical implications. It is a crucial resource that not \nonly educates the audience but also encourages further re-\nsearch and a holistic approach to addressing endometrio-\nsis-associated ovarian cancer, ultimately contributing to \nenhanced healthcare and well-being for those affected. \nSubmitted: November 24, 2024 CST, Accepted: November 24, \n2024 CST \nYounis J. The risk of endometriosis-associated ovarian cancer. Journal of IVF-Worldwide.\n2024;2(4.1):1-2. doi:10.46989/001c.126484\n\nThis is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License \n(CCBY-NC-SA-4.0). View this license’s legal deed at https://creativecommons.org/licenses/by-nc-sa/4.0 and legal code at \nhttps://creativecommons.org/licenses/by-nc-sa/4.0/legalcode for more information. \nThe risk of endometriosis-associated ovarian cancer\nJournal of IVF-Worldwide 2","source_license":"CC0","license_restricted":false}